preferred_name: Monitor closely for respiratory depression in at-risk patients (e.g., older than 70 years; history of sleep apnea; concurrent use of PCA with a central nervous system depressant; obesity; upper abdominal or thoracic surgery and PCA bolus of greater than 1 mg; history of renal, hepatic, pulmonary, or cardiac impairment)